Board logo

subject: Global Top 10 Pharmaceutical Companies - Industry, Financial And Swot Analysis [print this page]


Introduction
Introduction

This report analyzes the global pharmaceutical market in terms of market size, key drivers and resistors, trends and competitive positioning. It includes profiles of the top ten companies in the industry along with 5-year financial analysis and in-depth SWOT analysis.

Scope

*Performance of the global pharmaceutical market on the basis of sales, volume and respective growth patterns over the past five years

*Obtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the last 12 months

*Analysis of the Strengths, Weaknesses, Opportunities and Threats of the top 10 pharmaceutical companies along with business overview and financials

*Benchmark the performance of the top 10 players for the past five years; includes revenue comparison, profitability analysis, industry-specific ratios

Highlights

The global pharmaceutical market generated total revenues of $615.1 billion in 2008, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2004-2008.

The cardiovascular segment was the market's most lucrative in 2008, generating total revenues of $121.7 billion, equivalent to 19.8% of the market's overall value.

The performance of the market is forecast to decelerate, with an anticipated CAGR of 3.6% for the five-year period 2008-2013, which is expected to drive the market to a value of $734 billion by the end of 2013.

Reasons to Purchase

*Save time, money and resources on analyzing the top 10 pharmaceutical companies using this report

*Analyze the global pharmaceutical market with key industry metrics including market value, market volume, and growth forecasts

*Assess the intensity of competition based on the 5-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power

Table of Contents :

FIGURES 3

Tables 4

Executive Summary 5

Industry analysis 5

Industry definition 5

Research highlights 5

Top 10 companies landscape 5

Market value 7

Market forecast 8

Market segmentation-product 9

Market segmentation-geographic 10

Five Forces Analysis 11

Summary 11

Buyer power 12

Supplier power 13

New entrants 14

Substitutes 15

Rivalry 16

Top 10 Companies Landscape 17

Overview 17

Pfizer 18

GlaxoSmithKline 18

F, Hoffmann-La Roche 19

Novartis 19

Sanofi-Aventis 19

AstraZeneca 19

Abbott Laboratories 19

Merck & Co. 19

Wyeth 20

Bristol-Myers Squibb Company 20

Revenue analysis 21

Financial performance analysis 23

Operating profit analysis 24

Net profit analysis 25

Ratio analysis 26

Company Reports 28

Pfizer Inc 28

Company overview 28

Business description 28

SWOT analysis 29

Strengths 29

Weaknesses 29

Opportunities 30

Threats 31

Recent developments 32

GlaxoSmithKline Plc 34

Company overview 34

Business description 34

SWOT analysis 35

Strengths 35

Weaknesses 36

Opportunities 37

Threats 38

Recent developments 38

F. Hoffmann-La Roche 40

Company overview 40

Business description 40

SWOT analysis 41

Strengths 41

Weaknesses 41

Opportunities 42

Threats 43

Recent developments 43

Novartis 45

Company overview 45

Business description 45

SWOT analysis 46

Strengths 46

Weaknesses 47

Opportunities 47

Threats 48

Recent developments 48

Sanofi-Aventis 50

Company overview 50

Business description 50

SWOT analysis 50

Strengths 50

Weaknesses 52

Opportunities 53

Threats 54

Recent developments 55

AstraZeneca 57

Company overview 57

Business description 57

SWOT analysis 58

Strengths 58

Weaknesses 59

Opportunities 60

Threats 62

Recent developments 62

Abbott Laboratories 64

Company overview 64

Business description 64

SWOT analysis 65

Strengths 65

Weaknesses 66

Opportunities 67

Threats 67

Recent developments 68

Merck & Co., Inc. 70

Company overview 70

Business description 70

SWOT analysis 71

Strengths 71

Weaknesses 71

Opportunities 72

Threats 74

Recent developments 74

Wyeth 77

Company overview 77

Business description 77

SWOT analysis 78

Strengths 78

Weaknesses 78

Opportunities 79

Threats 79

Recent developments 79

Bristol-Myers Squibb Company 82

Company overview 82

Business description 82

SWOT analysis 83

Strengths 83

Weaknesses 84

Opportunities 84

Threats 85

Recent developments 86

Five Year Financial Information 88

Pfizer 88

GlaxoSmithKline 91

F. Hoffman-La Roche 94

Novartis 97

Sanofi-Aventis 100

AstraZeneca 103

Abbott Laboratories 106

Merck & Co. 109

Wyeth 112

Bristol-Myers Squibb Company 115

APPENDIX 118

For more information, please visit :

http://www.aarkstore.com/reports/Global-Top-10-Pharmaceutical-Companies-Industry-Financial-and-SWOT-Analysis-45632.html

by: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)